Eli Lilly is set on releasing a new line of digital insulin pens for the US market. Currently available in Europe, Huma-Pen Memoir is thought to help patients manage their insulin dosages and avoid dangerous overdoses.
The injector, which hides a hypodermic needle, was unveiled today at Battelle. It is the newest in a line the lab designed for Eli Lilly, the Indianapolis-based pharmaceutical company.The device, called the Huma-Pen Memoir, uses insulin cartridges. It will go on sale next week and retail for about $45.
'It allows the user to dial the amount of insulin they need to take. Most people take insulin three or four times a day, depending on when they eat,' said Doug Boyd, who led the Battelle development team.
The HumaPen records the dose, date and time of the past 16 injections. The memory is a safety feature for diabetics.
'Overdosing is life-threatening,' Boyd said.
Directions for Use
Advertisement
The device looks like a fountain pen. The pen is designed to last about three years, containing 115 parts.
To conclude, the diabetics say that they can see how the memory feature would be helpful for them.
Advertisement
SRI
